![]() |
市场调查报告书
商品编码
1625185
到 2030 年自动缝合设备市场预测:按产品类型、技术、分销管道、应用、最终用户和地区进行的全球分析Automated Suturing Devices Market Forecasts to 2030 - Global Analysis By Product Type, Technology, Distribution Channel, Application, End User and By Geography |
根据Stratistics MRC预测,2024年全球自动缝合设备市场规模将达35亿美元,预计在预测期内复合年增长率为9.4%,到2030年将达到60亿美元。
自动缝合设备是先进的手术器械,旨在实现各种医疗手术中缝合过程的自动化。这些设备包括允许精确缝合组织、减少人为错误并提高手术效率的机制。自动缝合装置有一次性和可重复使用两种类型,应用范围广泛,从普通外科到心臟、胸腔外科和胃肠外科等专业领域。
根据世界卫生组织估计,全球约有119万人死于交通事故,2,000万至5,000万人遭受非致命伤害。
微创手术需求不断成长
对微创手术(MIS)的日益偏好是推动自动缝合设备市场成长的主要因素。随着患者和医疗保健提供者寻求切口更小、疤痕更少、恢復时间更快和感染风险更低的手术,MIS 变得越来越受欢迎。自动缝合设备在这些手术中发挥关键作用,可以提高准确性、减少人为错误并简化缝合过程。透过提高效率和加速伤口缝合,这些设备有助于 MIS 的成功。随着微创手术的全球趋势持续成长,对自动化缝合解决方案的需求预计将会增加。
培训和技能需求
对专业培训和技能的需求是自动缝合设备市场的主要挑战。这些设备提高了准确性和效率,但需要医疗保健专业人员(尤其是外科医生)进行专门培训才能有效操作。训练不足可能会导致手术过程中表现不佳和出现错误。此外,医院和手术中心必须投入时间和资源来培训员工,这可能会延迟新技术的实施。这些熟练人员的要求可能会阻碍自动缝合技术的广泛使用,特别是在资源匮乏的地区。
新兴市场医疗保健基础设施的成长
新兴市场医疗保健基础设施的扩张推动了对自动缝合设备的需求。随着中东、亚太和拉丁美洲国家投资现代化和扩大其医疗保健系统,先进的医疗技术变得越来越必要。随着医疗机构努力提高业务效率、缩短恢復时间并改善手术效果,自动缝合设备变得越来越受欢迎。外科手术数量的增加和微创技术知识的增加进一步加速了这些设备的采用并推动了新兴国家的市场扩张。
初始成本高
自动缝合设备的高昂初始成本是广泛采用的主要障碍,特别是在资源匮乏的环境中。由于初始成本高昂,先进设备,特别是机器人辅助缝合系统,对于开发中国家的小型诊所、医院和医疗机构来说是遥不可及的。由于维护、培训和灭菌要求较高,整体成本可能会增加。儘管这些技术在准确性和效率方面具有长期优势,但其初始成本可能会阻止医疗相关人员将其纳入外科手术中,并可能限制某些市场的市场扩张。
COVID-19 的影响
COVID-19大流行对自动缝合设备市场产生了重大影响。最初,随着择期手术被推迟以优先治疗 COVID-19 患者,对这些设备的需求下降。然而,随着疫情的发展,由于与 COVID-19併发症相关的手术数量增加,以及为降低感染风险而采用微创手术的情况增多,对这些设备的需求增加。此外,疫情也加速了自动缝合设备等先进技术的采用,以提高效率并降低接触病毒的风险。
普通外科预计将成为预测期内最大的细分市场
由于需要提高准确性、减少手术时间和改善患者治疗效果,一般外科领域估计是最大的。这些设备提供更快、更一致的缝合,这在疝气修復、阑尾和胆囊手术等常规手术中尤其有价值。此外,人们越来越关注需要精确组织闭合的微创手术,导致更多地采用自动缝合设备,从而提高手术效率并降低併发症率。
研究机构领域预计在预测期内复合年增长率最高
研究机构部门预计在预测期内将出现最高的复合年增长率,因为它负责推进外科技术和技术。这些研究机构特别专注于开发自动缝合设备在复杂和专业手术中的新应用。此外,与医疗设备製造商的合作推动了临床研究,以确保自动缝合设备满足不断变化的手术需求并有助于改善患者的治疗效果。
由于医疗基础设施的快速进步、手术数量的增加以及微创手术 (MIS) 的采用不断增加,预计亚太地区在预测期内将占据最大的市场占有率。随着中国、印度和日本等国家投资现代化医疗保健系统,先进手术技术的需求不断增加。此外,该地区人口众多且老化,以及医疗创新的普及,刺激了对自动缝合设备等精确高效手术器械的需求,进一步推动了马苏市场的成长。
预计北美地区在预测期内的复合年增长率最高。这是由于先进的医疗基础设施、微创手术 (MIS) 的高采用率以及对精准手术的日益关注。该地区人口老化和外科手术数量的增加进一步增加了对高效可靠缝合解决方案的需求。此外,领先医疗设备製造商的存在、机器人辅助手术技术创新的增加以及医疗保健支出的增加都有助于市场成长,使北美成为自动缝合设备的关键市场。
According to Stratistics MRC, the Global Automated Suturing Devices Market is accounted for $3.50 billion in 2024 and is expected to reach $6.00 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Automated suturing devices are advanced surgical tools designed to automate the suturing process during various medical procedures. These devices are equipped with mechanisms that enable precise stitching of tissues, reducing human error and enhancing surgical efficiency. Automated suturing devices can be disposable or reusable, and are employed in applications ranging from general surgery to specialized fields like cardiothoracic and gastrointestinal surgery.
According to WHO estimates approximately 1.19 million people die due to road traffic crashes, and between 20 and 50 million more suffer non-fatal injuries globally.
Growing demand for minimally invasive surgeries
The increasing preference for minimally invasive surgeries (MIS) is a key factor driving the growth of the automated suturing devices market. As patients and healthcare providers seek procedures that offer smaller incisions, reduced scarring, quicker recovery times, and lower risk of infection, MIS has gained widespread popularity. Automated suturing devices play a critical role in these procedures, enhancing precision, reducing human error, and streamlining the suturing process. By improving efficiency and enabling faster wound closure, these devices contribute to the success of MIS. As the global trend toward minimally invasive procedures continues to grow, it is expected that demand for automatic suturing solutions will increase.
Training and skill requirements
The need for specialized training and skills poses a considerable challenge in the automated suturing devices market. While these devices offer enhanced precision and efficiency, they require healthcare professionals, particularly surgeons, to undergo specialized training to operate them effectively. Inadequate training may lead to suboptimal performance or errors during procedures. Furthermore, hospitals and surgical centers must invest time and resources in training staff, which can delay the adoption of new technologies. This requirement for skilled personnel may hinder the widespread use of automated suturing technology, particularly in areas with low resources.
Healthcare infrastructure growth in emerging markets
The need for automated suturing devices is being driven by the expansion of healthcare infrastructure in emerging markets. Advanced medical technology are becoming more and more necessary as nations in the Middle East, Asia-Pacific, and Latin America make investments to modernize and expand their healthcare systems. As medical facilities strive to increase operational efficiency, decrease recuperation times, and improve surgical results, automated suturing devices are becoming more and more popular. Further accelerating up the adoption of these devices and promoting market expansion in emerging nations are the increasing number of surgical procedures and increased knowledge of minimally invasive techniques.
High initial cost
The substantial upfront cost of automated suturing devices poses a major obstacle to their widespread adoption, particularly in resource-limited environments. Due to their high upfront costs, advanced devices especially robotic-assisted suturing systems are less affordable for smaller clinics, hospitals, and healthcare facilities in developing nations. The overall cost may be increased by the high cost of maintenance, training, and sterilization requirements. Although these technologies have long-term advantages in terms of accuracy and efficiency, the initial cost might deter medical professionals from incorporating them into their surgical procedures, which might hinder market expansion in certain markets.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the automated suturing devices market. Initially, the demand for these devices decreased due to the postponement of elective surgeries to prioritize COVID-19 patient care. However, as the pandemic progressed, the demand for these devices increased due to the rising number of surgeries related to COVID-19 complications and the increasing adoption of minimally invasive surgeries to reduce the risk of infection. Additionally, the pandemic accelerated the adoption of advanced technologies, including automated suturing devices, to improve efficiency and reduce the risk of exposure to the virus.
The general surgery segment is expected to be the largest during the forecast period
The general surgery segment is estimated to be the largest, due to the need for enhanced precision, reduced surgical time, and improved patient outcomes. These devices offer faster and more consistent suturing, which is especially valuable in routine procedures such as hernia repairs, appendectomies, and gallbladder surgeries. Additionally, the increasing focus on minimally invasive techniques, which require precise tissue closure, has led to greater adoption of automated suturing devices, improving surgical efficiency and reducing complication rates.
The research institutions segment is expected to have the highest CAGR during the forecast period
The research institutions segment is anticipated to witness the highest CAGR during the forecast period, due to their role in advancing surgical technologies and techniques. These institutions are focused on exploring new applications for automated suturing devices, particularly in complex or specialized surgeries. Additionally, research collaborations with medical device manufacturers help to drive clinical studies, ensuring that automated suturing devices meet evolving surgical needs and contribute to better patient outcomes.
Asia Pacific is expected to have the largest market share during the forecast period due to rapid advancements in healthcare infrastructure, rising surgical volumes, and increasing adoption of minimally invasive surgery (MIS). As countries like China, India, and Japan invest in modernizing their healthcare systems, there is growing demand for advanced surgical technologies. Additionally, the region's large and aging population, along with improving access to medical innovations, fuels the need for precise, efficient surgical tools like automated suturing devices, further driving market growth.
During the forecast period, the North America region is anticipated to register the highest CAGR, driven by advanced healthcare infrastructure, high adoption of minimally invasive surgeries (MIS), and a growing focus on precision surgery. The region's aging population and increasing incidence of surgical procedures further boost demand for efficient and reliable suturing solutions. Additionally, the strong presence of leading medical device manufacturers, ongoing innovations in robotic-assisted surgeries, and higher healthcare spending contribute to the market's growth, positioning North America as a key market for automated suturing devices.
Key players in the market
Some of the key players profiled in the Automated Suturing Devices Market include Medtronic, Stryker Corporation, Smith & Nephew, B. Braun Melsungen AG, Intuitive Surgical, ConMed Corporation, KARL STORZ GmbH & Co. KG, Applied Medical Resources Corporation, Teleflex Incorporated, Toshiba Medical Systems Corporation, Zimmer Biomet, Boston Scientific, Cook Medical, Inovio Pharmaceuticals, 3M, LivaNova PLC, and Hoya Corporation.
In April 2021, Medtronic announced its partnership with Surgical Theater, a startup that markets a Surgery Rehearsal Platform. With the initiative, the companies focused on integrating SynAR's augmented reality of Surgical Theater with Medtronic's StealthStation S8 surgical navigation system.
In September 2020, Smith &Nephew launched Healicoil Knotless Suture Anchor, an addition to its range of modern healing technology for rotator cuff treatment.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.